Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.54 |
| ▸ | CA12 | O43570 | 3/20 | 0.54 |
| ▸ | CA1 | P00915 | 3/20 | 0.54 |
| ▸ | CA7 | P43166 | 3/20 | 0.54 |
| ▸ | CA9 | Q16790 | 3/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.54 |
| ▸ | ACHE | P22303 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 2/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.45 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.45 |
| ▸ | CA6 | P23280 | 1/20 | 0.45 |
| ▸ | TPMT | P51580 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31277237 | 1.00 | CA2 (0.54) | CA2CA12CA1CA7CA9 | |
| SCHEMBL16174318 | 0.86 | CA2 (0.41) | CA2CA12CA1CA7CA9 | |
| SCHEMBL31098551 | 0.83 | PDE4A (0.50) | TSHRALDH1A1MAPK1PDE4AAPP | |
| SCHEMBL8123915 | 0.83 | PDE4A (0.50) | TSHRALDH1A1MAPK1PDE4AAPP | |
| SCHEMBL4152456 | 0.83 | PDE4B (0.42) | CA2CA12CA1CA7CA9 | |
| SCHEMBL11439070 | 0.83 | KDM4E (0.59) | TSHRALDH1A1MAPK1PDE4AAPP | |
| SCHEMBL20553872 | 0.83 | CA2 (0.39) | CA2CA12CA1CA7CA9 | |
| SCHEMBL197234 | 0.82 | APP (0.38) | CA2CA12CA1CA7CA9 | |
| SCHEMBL482383 | 0.82 | CA2 (0.41) | CA2CA12CA1CA7CA9 | |
| SCHEMBL3548000 | 0.81 | CYP1A2 (0.40) | CA2CA12CA1CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110615801-A | Preparation method and application of triazine compound with polyvinyl chloride light stabilization effect | 河南龙湖生物技术有限公司 | 2019-12-27 | — | — | CN | claimed |
| CN-110204555-A | The preparation method and application of compound in triazine class with polyvinyl chloride light stabilization | 河南龙湖生物技术有限公司 | 2019-09-06 | — | — | CN | claimed |
| CN-105732333-B | A kind of preparation method of the trichloro-benzene of 1,2 dimethoxy, 4 iodobenzene 3,5,6 | 天津城建大学 | 2018-01-12 | — | — | CN | claimed |
| CN-105732333-A | Preparation method of 1,2-dimethoxy-4-iodobenzene-3,5,6-trichlorobenzene | 天津城建大学 | 2016-07-06 | — | — | CN | claimed |
| CN-101861325-A | In the chemical reaction that the aryl boric acid that use replaces through the ortho position carries out, carboxylic acid is carried out organic catalysis activatory method | UNIV ALBERTA | 2010-10-13 | — | — | CN | claimed |
| CN-1330679-A | Plastic moulding materials which can be detected by x-ray contrast | BAYER AG (DE) | 2002-01-09 | — | — | CN | claimed |
| EP-1155073-A1 | PLASTIC MOULDING MATERIALS WHICH CAN BE DETECTED BY X-RAY CONTRAST | Bayer Aktiengesellschaft (DE) | 2001-11-21 | — | — | EP | claimed |
| WO-2000036002-A1 | PLASTIC MOULDING MATERIALS WHICH CAN BE DETECTED BY X-RAY CONTRAST | BAYER AKTIENGESELLSCHAFT (DE) | 2000-06-22 | — | — | WO | claimed |
| EP-4743453-A1 | MODULATORS OF MITOCHONDRIAL DNA REPLICATION | Pretzel Therapeutics, Inc. (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-4688796-A1 | ARYL-HETEROCYCLE-PYRROLE CATALYSTS FOR OLEFIN POLYMERIZATION | Dow Global Technologies LLC (US) | 2026-02-11 | — | — | EP | disclosed |
| EP-4665718-A1 | SMALL MOLECULES AS MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS, COMPOSITIONS AND USE THEREOF | Apogee Pharmaceuticals, Inc. (CA) | 2025-12-24 | — | — | EP | disclosed |
| US-12378231-B2 | Small molecules as monoacylglycerol lipase (MAGL) inhibitors, compositions and use thereof | APOGEE PHARMACEUTICALS, INC. (CA) | 2025-08-05 | — | — | US | disclosed |
| WO-2025015178-A1 | MODULATORS OF MITOCHONDRIAL DNA REPLICATION | PRETZEL THERAPEUTICS, INC. (US) | 2025-01-16 | — | — | WO | disclosed |
| US-12186313-B2 | Pyridazinone compounds and their use as DAAO inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2025-01-07 | — | — | US | disclosed |
| US-5384068-A | Switchable columnar liquid-crystalline systems | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-01-24 | — | — | US | disclosed |
| US-4910200-A | Agricultural fungicide | CELAMERCK GMBH & CO. KG (DE) | 1990-03-20 | — | — | US | disclosed |
| US-4910198-A | Antiarrhythmia agent | ORTHO PHARMACEUTICAL CORPORATION (US) | 1990-03-20 | — | — | US | disclosed |
| US-4855426-A | Process of preparing 1,5-epoxy-2,3,4,5-tetrahydro-1H-3-benzazepins | ORTHO PHARMACEUTICAL CORPORATION (US) | 1989-08-08 | — | — | US | disclosed |
| US-4761413-A | CYTOPROTECTION, ANTISECRETORY AGENTS | ORTHO PHARMACEUTICAL CORPORATION (US) | 1988-08-02 | — | — | US | disclosed |
| US-4118507-A | Benzodioxincarboxamide lipogenesis inhibitors | SHELL OIL COMPANY (US) | 1978-10-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12186313-B2 | Pyridazinone compounds and their use as DAAO inhibitors | PNPO, DAO, DPYD | CA2 3315/4885CA12 3332/4885CA1 3015/4885 |
| US-12378231-B2 | Small molecules as monoacylglycerol lipase (MAGL) inhibitors, compositions and use thereof | MGLL, PNLIP, LPL | CA2 4149/4885CA12 4075/4885CA1 2311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.